Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Type Dementia”

180 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 180 results

Not applicableLooking for participantsNCT06965062
What this trial is testing

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Who this might be right for
Alzheimer DiseaseDementia Alzheimer TypeDementia Alzheimer's Type+2 more
Vincent Tay Khwee Soon 10
Not applicableUnknownNCT05113732
What this trial is testing

Association of Cognition With Functional Mobility in People With Alzheimer's Disease

Who this might be right for
Alzheimer DementiaAlzheimer's DiseaseDementia, Alzheimer Type
Istanbul University - Cerrahpasa 64
Large-scale testing (Phase 3)Study completedNCT02442765
What this trial is testing

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Not applicableStudy completedNCT02460783
What this trial is testing

Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function

Who this might be right for
Alzheimer's DiseaseObesityDiabetes Mellitus
National Institute on Aging (NIA) 129
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Large-scale testing (Phase 3)Ended earlyNCT00380276
What this trial is testing

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Who this might be right for
Alzheimer's Disease
Myrexis Inc. 1,000
Not applicableStudy completedNCT01819714
What this trial is testing

Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nīmes 31
Not applicableEnrolling By InvitationNCT05704309
What this trial is testing

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Who this might be right for
DiabetesAlzheimer DiseaseDementia, Vascular+2 more
Marinella Temprosa 1,976
Large-scale testing (Phase 3)Ended earlyNCT00160147
What this trial is testing

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Who this might be right for
Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Solvay Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT01273272
What this trial is testing

Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers

Who this might be right for
Alzheimer Disease
University of Zurich 50
Large-scale testing (Phase 3)Study completedNCT03226522
What this trial is testing

Addressing Dementia Via Agitation-Centered Evaluation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 366
Not applicableStudy completedNCT07677865
What this trial is testing

GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

Who this might be right for
Alzheimer DiseaseDiabetes Mellitus Type 2Obesity & Overweight
West China Hospital 213,891
Large-scale testing (Phase 3)Active Not RecruitingNCT01760005
What this trial is testing

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

Who this might be right for
Alzheimers DiseaseDementiaAlzheimers Disease, Familial
Washington University School of Medicine 490
Testing effectiveness (Phase 2)Study completedNCT00130429
What this trial is testing

Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Phytopharm 250
Not applicableUnknownNCT03959124
What this trial is testing

Deep Brain Stimulation for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer TypeDeep Brain Stimulation
Buddhist Tzu Chi General Hospital 30
Large-scale testing (Phase 3)Study completedNCT00099242
What this trial is testing

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia, Alzheimer Type
Novartis Pharmaceuticals 1,040
Testing effectiveness (Phase 2)Study completedNCT00842673
What this trial is testing

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sonexa Therapeutics, Inc. 168
Early research (Phase 1)Study completedNCT02859207
What this trial is testing

Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06362707
What this trial is testing

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Who this might be right for
Cognitive Decline, MildAlzheimer Disease
Helse Stavanger HF 200
Next Page